U10CA32115/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1999	2
2002	1
2003	2
2004	1
2005	1
2007	1
2008	1
2009	2
2010	1
2011	1
2012	1
2014	1
2015	2
2016	1
2024	0

1

Clinical outcome of patients treated with 3D conformal radiation therapy (3D-CRT) for prostate cancer on RTOG 9406.

Michalski J, Winter K, Roach M, Markoe A, Sandler HM, Ryu J, Parliament M, Purdy JA, Valicenti RK, Cox JD. Michalski J, et al. Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):e363-70. doi: 10.1016/j.ijrobp.2011.12.070. Int J Radiat Oncol Biol Phys. 2012. PMID: 22633552 Free PMC article. Clinical Trial.

2

Irradiation with or without misonidazole for patients with stages IIIB and IVA carcinoma of the cervix: final results of RTOG 80-05. Radiation Therapy Oncology Group.

Grigsby PW, Winter K, Wasserman TH, Marcial V, Rotman M, Cooper J, Keys H, Asbell SO, Phillips TL. Grigsby PW, et al. Int J Radiat Oncol Biol Phys. 1999 Jun 1;44(3):513-7. doi: 10.1016/s0360-3016(99)00054-1. Int J Radiat Oncol Biol Phys. 1999. PMID: 10348279 Clinical Trial.

3

Prognostic factors derived from a prospective database dictate clinical biology of anal cancer: the intergroup trial (RTOG 98-11).

Ajani JA, Winter KA, Gunderson LL, Pedersen J, Benson AB 3rd, Thomas CR Jr, Mayer RJ, Haddock MG, Rich TA, Willett CG. Ajani JA, et al. Cancer. 2010 Sep 1;116(17):4007-13. doi: 10.1002/cncr.25188. Cancer. 2010. PMID: 20564111 Free PMC article.

4

US intergroup anal carcinoma trial: tumor diameter predicts for colostomy.

Ajani JA, Winter KA, Gunderson LL, Pedersen J, Benson AB 3rd, Thomas CR Jr, Mayer RJ, Haddock MG, Rich TA, Willett CG. Ajani JA, et al. J Clin Oncol. 2009 Mar 1;27(7):1116-21. doi: 10.1200/JCO.2008.19.6857. Epub 2009 Jan 12. J Clin Oncol. 2009. PMID: 19139424 Free PMC article.

5

Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.

Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, Rotman M, Gershenson DM, Mutch DG. Morris M, et al. N Engl J Med. 1999 Apr 15;340(15):1137-43. doi: 10.1056/NEJM199904153401501. N Engl J Med. 1999. PMID: 10202164 Free article. Clinical Trial.

6

Phase III quality-of-life study results: impact on patients' quality of life to reducing xerostomia after radiotherapy for head-and-neck cancer--RTOG 97-09.

Fisher J, Scott C, Scarantino CW, Leveque FG, White RL, Rotman M, Hodson DI, Meredith RF, Foote R, Bachman DG, Lee N. Fisher J, et al. Int J Radiat Oncol Biol Phys. 2003 Jul 1;56(3):832-6. doi: 10.1016/s0360-3016(03)00121-4. Int J Radiat Oncol Biol Phys. 2003. PMID: 12788192 Clinical Trial.

7

Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01.

Movsas B, Scott C, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, Machtay M, Smith C, Axelrod R, Sarna L, Wasserman T, Byhardt R. Movsas B, et al. J Clin Oncol. 2005 Apr 1;23(10):2145-54. doi: 10.1200/JCO.2005.07.167. J Clin Oncol. 2005. PMID: 15800308 Clinical Trial.

8

Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: findings from a prospective, multi-institutional, phase I/II dose-escalation study.

Roach M, Winter K, Michalski JM, Cox JD, Purdy JA, Bosch W, Lin X, Shipley WS. Roach M, et al. Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1351-6. doi: 10.1016/j.ijrobp.2004.05.026. Int J Radiat Oncol Biol Phys. 2004. PMID: 15590164 Clinical Trial.

9

RECQ1 A159C Polymorphism Is Associated With Overall Survival of Patients With Resected Pancreatic Cancer: A Replication Study in NRG Oncology Radiation Therapy Oncology Group 9704.

Li D, Moughan J, Crane C, Hoffman JP, Regine WF, Abrams RA, Safran H, Liu C, Chang P, Freedman GM, Winter KA, Guha C, Abbruzzese JL. Li D, et al. Int J Radiat Oncol Biol Phys. 2016 Mar 1;94(3):554-60. doi: 10.1016/j.ijrobp.2015.10.062. Epub 2015 Nov 5. Int J Radiat Oncol Biol Phys. 2016. PMID: 26725729 Free PMC article. Clinical Trial.

10

Glycogen Synthase Kinase 3 Beta Predicts Survival in Resected Adenocarcinoma of the Pancreas.

Ben-Josef E, George A, Regine WF, Abrams R, Morgan M, Thomas D, Schaefer PL, DiPetrillo TA, Fromm M, Small W Jr, Narayan S, Winter K, Griffith KA, Guha C, Williams TM. Ben-Josef E, et al. Clin Cancer Res. 2015 Dec 15;21(24):5612-8. doi: 10.1158/1078-0432.CCR-15-0789. Epub 2015 Aug 3. Clin Cancer Res. 2015. PMID: 26240274 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

16 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year